Company · CIK 0001023024 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ANI PHARMACEUTICALS INC · ANIP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 16, 4:20 pm EDT | Nikhil LalwaniPRESIDENT & CEO, Director | 5,400 | $71.00 | $383,400 | 339,089 | −1.57% | 10b5-1 |
| Sep 14, 2026 SForm 4 → | Sep 14, 8:56 pm EDT | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | 500 | $70.79 | $35,395 | 73,924 | −0.67% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 14, 8:57 pm EDT | Jeanne ThomaDirector | 1,000 | $71.53 | $71,530 | 26,762 | −3.60% | 10b5-1 |
| Aug 31, 2026 SForm 4 → | Sep 1, 6:18 pm EDT | Stephen P. CareySVP & CFO | 2,850 | $72.80 | $207,480 | 171,843 | −1.63% | 10b5-1 |
| Aug 25, 2026 SForm 4 → | Aug 26, 6:15 pm EDT | Nikhil LalwaniPRESIDENT & CEO, Director | 5,400 | $74.30 | $401,220 | 344,489 | −1.54% | 10b5-1 |
| Aug 19, 2026 AForm 4 → | Aug 27, 4:21 pm EDT | Henry O GosebruchDirector | 6,662 | — | — | 6,662 | — | late |
| Aug 13, 2026 SForm 4 → | Aug 13, 4:32 pm EDT | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | 500 | $75.48 | $37,740 | 74,424 | −0.67% | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 11, 8:57 pm EDT | Ori GutwergSVP, GENERICS | 3,162 | $77.00 | $243,474 | 75,534 | −4.02% | |
| Jul 29, 2026 SForm 4 → | Jul 30, 4:02 pm EDT | Stephen P. CareySVP & CFO | 2,850 | $81.36 | $231,876 | 174,693 | −1.61% | 10b5-1 |
| Jul 18, 2026 FForm 4 → | Jul 21, 4:32 pm EDT | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | 2,466 | $79.20 | $195,307 | 74,924 | — | |
| Jul 13, 2026 SForm 4 → | Jul 14, 4:02 pm EDT | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | 500 | $81.84 | $40,920 | 77,390 | −0.64% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 6, 9:40 pm EDT | Stephen P. CareySVP & CFO | 3,313 | $86.00 | $284,918 | 177,543 | −1.83% | 10b5-1 |
| Jul 2, 2026 MForm 4 → | Jul 6, 9:40 pm EDT | Stephen P. CareySVP & CFO | 3,313 | $49.51 | $164,027 | 180,856 | — | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 30, 4:14 pm EDT | Stephen P. CareySVP & CFO | 2,850 | $84.12 | $239,742 | 177,543 | −1.58% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 MForm 4 → | Jul 6, 9:40 pm EDT | Stephen P. CareySVP & CFO | 3,313 | $49.51 | $164,027 | 3,313 | — | 10b5-1 |